NO154346C - Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater.Info
- Publication number
- NO154346C NO154346C NO784397A NO784397A NO154346C NO 154346 C NO154346 C NO 154346C NO 784397 A NO784397 A NO 784397A NO 784397 A NO784397 A NO 784397A NO 154346 C NO154346 C NO 154346C
- Authority
- NO
- Norway
- Prior art keywords
- phtalazin
- preparation
- acetic acid
- acid derivatives
- therapeutically active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5414277 | 1977-12-29 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO784397L NO784397L (no) | 1979-07-02 |
NO154346B NO154346B (no) | 1986-05-26 |
NO154346C true NO154346C (no) | 1986-09-03 |
Family
ID=10470067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO784397A NO154346C (no) | 1977-12-29 | 1978-12-28 | Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater. |
Country Status (31)
Country | Link |
---|---|
US (2) | US4251528A (no) |
EP (1) | EP0002895B1 (no) |
JP (2) | JPS5495582A (no) |
AT (1) | AT365581B (no) |
AU (1) | AU516264B2 (no) |
BG (1) | BG34336A3 (no) |
CA (1) | CA1107732A (no) |
CS (1) | CS241015B2 (no) |
CY (1) | CY1219A (no) |
DD (1) | DD141021A5 (no) |
DE (1) | DE2861170D1 (no) |
DK (1) | DK151253C (no) |
ES (1) | ES476496A1 (no) |
FI (1) | FI64357C (no) |
GR (1) | GR65303B (no) |
HK (1) | HK22484A (no) |
HU (1) | HU182585B (no) |
IE (1) | IE47592B1 (no) |
IL (1) | IL56099A0 (no) |
IN (1) | IN150196B (no) |
IT (1) | IT1110885B (no) |
MY (1) | MY8500359A (no) |
NO (1) | NO154346C (no) |
NZ (1) | NZ189034A (no) |
PH (1) | PH15435A (no) |
PL (1) | PL118443B1 (no) |
PT (1) | PT68956A (no) |
SG (1) | SG68683G (no) |
SU (3) | SU1087075A3 (no) |
YU (3) | YU41607B (no) |
ZW (1) | ZW24978A1 (no) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE47592B1 (en) * | 1977-12-29 | 1984-05-02 | Ici Ltd | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture |
CA1143733A (en) * | 1979-07-31 | 1983-03-29 | Masao Yoshida | Producing 7-alkoxycarbonyl-6,8-dimethyl-4- hydroxymethyl-1-phthalazone and intermediates |
US4762839A (en) * | 1985-06-06 | 1988-08-09 | Tanabe Seiyaku Co., Ltd. | Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications |
DE3684410D1 (de) * | 1985-11-07 | 1992-04-23 | Pfizer | Heterocyclische oxophthalazinylessigsaeure. |
JPS63132889A (ja) * | 1986-11-21 | 1988-06-04 | Tanabe Seiyaku Co Ltd | キナゾリノン誘導体 |
US5011840A (en) * | 1986-11-24 | 1991-04-30 | Pfizer Inc. | Imidazolidinedione derivatives in diabetes treatment |
GB8704569D0 (en) * | 1987-02-26 | 1987-04-01 | Ici America Inc | Therapeutic agent |
US4868301A (en) * | 1987-06-09 | 1989-09-19 | Pfizer Inc. | Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains |
JPH0676391B2 (ja) * | 1987-06-09 | 1994-09-28 | フアイザー・インコーポレイテツド | ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法 |
DK607188A (da) * | 1987-11-02 | 1989-06-22 | Merck & Co Inc | Tablet indeholdende en phthalazineddikesyreforbindelse |
EP0315249A1 (en) * | 1987-11-02 | 1989-05-10 | Merck & Co. Inc. | Phthalazineacetic acid composition and tablet |
US4880928A (en) * | 1987-12-21 | 1989-11-14 | Merck & Co., Inc. | Process for the preparation of 3-((4-bromo-2-fluorophenyl)methyl)-3,4-dihydro-4-oxo-1-phthalazine-acetic acid |
US4940791A (en) * | 1988-02-29 | 1990-07-10 | Pfizer Inc. | Process for the production of phthalazineacetic acid ester derivatives and a novel hydrazine containing intermediate |
US4904782A (en) * | 1988-02-29 | 1990-02-27 | Pfizer Inc. | Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate |
US4954629A (en) * | 1989-05-11 | 1990-09-04 | Pfizer Inc. | Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof |
US4996204A (en) * | 1989-05-11 | 1991-02-26 | Pfizer Inc. | Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors |
EP0397930A1 (en) * | 1989-05-18 | 1990-11-22 | Merck & Co. Inc. | Process for the preparation of 3-[(4-bromo-2-fluorophenyl) methyl]-3,4-dihydro-4-oxo-1-phthalazineacetic acid |
FR2647676A1 (fr) * | 1989-06-05 | 1990-12-07 | Union Pharma Scient Appl | Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase |
WO1991009019A1 (en) * | 1989-12-15 | 1991-06-27 | Pfizer Inc. | Substituted oxophthalazinyl acetic acids and analogs thereof |
US5037831A (en) * | 1990-05-21 | 1991-08-06 | American Home Products Corporation | Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors |
FR2682108B1 (fr) * | 1991-10-07 | 1994-01-07 | Lipha | Acide 3,4-dihydro-4-oxo-3(prop-2-enyl)-1-phtalazineacetiques et derives, leurs preparations et medicaments les contenant. |
KR950703539A (ko) * | 1992-09-28 | 1995-09-20 | 알렌 제이. 스피겔 | 당뇨병 합병증 치료용 치환된 피리미딘(substituted pyrimidines for control or diabetic complications) |
WO1994010151A1 (en) * | 1992-11-02 | 1994-05-11 | Merck & Co., Inc. | Substituted phthalazinones as nerotensin antagonists |
CH683965A5 (it) * | 1993-02-19 | 1994-06-30 | Limad Marketing Exp & Imp | Composti della classe dei ftalidrazidici come sostanza attiva in agenti antinfiammatori ed antitossici. |
AU7195594A (en) * | 1993-07-26 | 1995-02-20 | Fujisawa Pharmaceutical Co., Ltd. | Oxophthalazines for treating cachexia |
US6696407B1 (en) | 1997-03-21 | 2004-02-24 | The Regents Of The University Of California | Huntington's disease treatment comprising administering aldose reductase inhibitors to increase striatal CNTF |
AU6473898A (en) * | 1997-03-21 | 1998-10-20 | Regents Of The University Of California, The | Methods for modulating neurotrophic factor-associated activity using aldose reductase inhibitors |
JP3553086B2 (ja) * | 1997-04-15 | 2004-08-11 | シーエスアイアール | 食欲抑制活性を有する医薬組成物 |
OA11622A (en) * | 1998-03-31 | 2004-09-16 | Inst For Pharm Discovery Inc | Substituted indolealkanoic acids. |
TNSN99224A1 (fr) | 1998-12-01 | 2005-11-10 | Inst For Pharm Discovery Inc | Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique |
GB2355657B (en) * | 1999-10-27 | 2004-07-28 | Phytopharm Plc | Inhibitors Of Gastric Acid Secretion |
DE19963607B4 (de) * | 1999-12-23 | 2005-12-15 | Schering Ag | Verfahren zur Herstellung von 4-(Heteroaryl-methyl) halogen-1(2H)-phthalazinonen |
GB2363985B (en) * | 2000-06-30 | 2004-09-29 | Phytopharm Plc | Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use |
EA200300433A1 (ru) * | 2000-11-30 | 2003-10-30 | Пфайзер Продактс Инк. | Комбинация гамк-агонистов и ингибиторов альдегидредуктазы |
EP1236720B1 (en) | 2001-02-28 | 2005-06-15 | Pfizer Products Inc. | Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors |
ATE348100T1 (de) | 2001-03-30 | 2007-01-15 | Pfizer Prod Inc | Zwischenprodukten für die herstellung von pyridazinon aldose reductase inhibitoren. |
HUP0303920A3 (en) * | 2001-04-30 | 2004-07-28 | Pfizer Prod Inc | Pharmaceutical compositions containing combinations of aldose reductase inhibitor pyridazinons and cyclooxygenase 2 inhibitors |
AU761191B2 (en) | 2001-05-24 | 2003-05-29 | Pfizer Products Inc. | Therapies for tissue damage resulting from ischemia |
WO2003092696A1 (en) * | 2002-04-30 | 2003-11-13 | Novartis Ag | Method for decreasing capillary permeability in the retina |
KR20050026002A (ko) * | 2002-07-26 | 2005-03-14 | 디 인스티튜트스 포 파마슈티컬 디스커버리, 엘엘씨 | 치환된 인돌알칸산 유도체 및 이를 함유하는 당뇨 합병증치료용 제형 |
US7572910B2 (en) * | 2003-02-20 | 2009-08-11 | Pfizer, Inc. | Pyridazinone aldose reductase inhibitors |
US20110092566A1 (en) * | 2004-11-19 | 2011-04-21 | Srivastava Satish K | Treatment of cancer with aldose reductase inhibitors |
JP4838582B2 (ja) * | 2004-12-27 | 2011-12-14 | 岐阜プラスチック工業株式会社 | 台車用本体 |
ES2371393T3 (es) | 2007-03-12 | 2011-12-30 | Zadec Aps | Extracto antidiabético de rooibos. |
EP2848252A3 (en) | 2007-03-23 | 2015-06-17 | The Board of Regents of the University of Texas System | Aldose reductase inhibitors for use in treating uveitis |
US20090270490A1 (en) * | 2008-04-24 | 2009-10-29 | The Board Of Regents Of The University Of Texas System | Methods involving aldose reductase inhibition |
EP2654749B1 (en) | 2010-12-23 | 2017-05-10 | The Board of Regents of The University of Texas System | Methods for treating copd |
CA2895162C (en) * | 2012-12-14 | 2021-03-09 | D. Lynn Kirkpatrick | Methods and compositions for inhibiting cnksr1 |
CA2983260C (en) | 2015-04-20 | 2024-01-23 | Phusis Therapeutics, Inc. | Sulfonamide compounds, compositions and methods for inhibiting cnksr1 |
WO2020071386A1 (ja) * | 2018-10-04 | 2020-04-09 | 日東電工株式会社 | 耐熱離型シート及び熱圧着方法 |
JP6751974B1 (ja) * | 2019-10-16 | 2020-09-09 | 株式会社コバヤシ | 離型フィルム及び離型フィルムの製造方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3833579A (en) * | 1935-11-11 | 1974-09-03 | Inoue Michiro | 4-carbamoyl phthalazones |
JPS5116430B2 (no) * | 1971-08-05 | 1976-05-24 | ||
GB1398549A (en) * | 1972-11-06 | 1975-06-25 | Boots Co Ltd | Phthalazine derivatives and their use in pharmaceutical compo sitions |
AR205004A1 (es) * | 1973-10-30 | 1976-03-31 | Ishikawa M | Procedimiento para preparar derivados de 6,8-dialquil-7-alcoxi-carbonil-4-hidroximetil-1-ftalazona y la 7,8-lactona |
DE2451117A1 (de) * | 1973-10-31 | 1975-05-22 | Boots Co Ltd | Therapeutisch wirksame verbindungen |
IE43079B1 (en) * | 1975-03-20 | 1980-12-17 | Ici Ltd | Quinolone derivatives |
GB1502312A (en) | 1975-03-20 | 1978-03-01 | Ici Ltd | Quinolone derivatives |
JPS5214788A (en) * | 1975-07-21 | 1977-02-03 | Fuji Photo Film Co Ltd | Process for preparing phthalazinone and its derivatives |
NL7702763A (nl) * | 1976-03-18 | 1977-09-20 | Takio Shimamoto En Masayuki Is | Werkwijze voor de bereiding van thromboxaan- -antagonisten en van preparaten die deze stof- fen bevatten. |
IE47592B1 (en) * | 1977-12-29 | 1984-05-02 | Ici Ltd | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture |
US4293553A (en) * | 1978-08-11 | 1981-10-06 | Masayuki Ishikawa | 1-Phthalazone derivatives, and use thereof |
-
1978
- 1978-11-27 IE IE2337/78A patent/IE47592B1/en not_active IP Right Cessation
- 1978-11-28 NZ NZ189034A patent/NZ189034A/xx unknown
- 1978-11-28 IN IN860/DEL/78A patent/IN150196B/en unknown
- 1978-11-29 AU AU42040/78A patent/AU516264B2/en not_active Expired
- 1978-11-29 US US05/964,725 patent/US4251528A/en not_active Expired - Lifetime
- 1978-11-30 DK DK541878A patent/DK151253C/da not_active IP Right Cessation
- 1978-11-30 IL IL56099A patent/IL56099A0/xx not_active IP Right Cessation
- 1978-12-01 EP EP78300720A patent/EP0002895B1/en not_active Expired
- 1978-12-01 DE DE7878300720T patent/DE2861170D1/de not_active Expired
- 1978-12-01 CY CY1219A patent/CY1219A/xx unknown
- 1978-12-06 PH PH21901A patent/PH15435A/en unknown
- 1978-12-12 GR GR57849A patent/GR65303B/el unknown
- 1978-12-14 FI FI783844A patent/FI64357C/fi not_active IP Right Cessation
- 1978-12-16 PL PL1978222157A patent/PL118443B1/pl unknown
- 1978-12-20 SU SU782698853A patent/SU1087075A3/ru active
- 1978-12-20 PT PT68956A patent/PT68956A/pt not_active IP Right Cessation
- 1978-12-21 JP JP15695378A patent/JPS5495582A/ja active Granted
- 1978-12-21 CA CA318,345A patent/CA1107732A/en not_active Expired
- 1978-12-22 HU HU78IE856A patent/HU182585B/hu not_active IP Right Cessation
- 1978-12-26 BG BG7841857A patent/BG34336A3/xx unknown
- 1978-12-28 ZW ZW249/78A patent/ZW24978A1/xx unknown
- 1978-12-28 CS CS789084A patent/CS241015B2/cs unknown
- 1978-12-28 IT IT52480/78A patent/IT1110885B/it active
- 1978-12-28 NO NO784397A patent/NO154346C/no unknown
- 1978-12-29 ES ES476496A patent/ES476496A1/es not_active Expired
- 1978-12-29 AT AT0937678A patent/AT365581B/de not_active IP Right Cessation
- 1978-12-29 DD DD78210284A patent/DD141021A5/de not_active IP Right Cessation
- 1978-12-29 YU YU3127/78A patent/YU41607B/xx unknown
-
1980
- 1980-10-06 US US06/194,211 patent/US4393062A/en not_active Expired - Lifetime
-
1981
- 1981-12-04 SU SU813359216A patent/SU1272984A3/ru active
- 1981-12-04 SU SU813359636A patent/SU1072803A3/ru active
-
1982
- 1982-10-14 YU YU2320/82A patent/YU42054B/xx unknown
- 1982-10-14 YU YU2321/82A patent/YU42807B/xx unknown
-
1983
- 1983-11-11 SG SG68683A patent/SG68683G/en unknown
-
1984
- 1984-03-15 HK HK224/84A patent/HK22484A/xx unknown
-
1985
- 1985-12-30 MY MY359/85A patent/MY8500359A/xx unknown
-
1987
- 1987-10-28 JP JP62270508A patent/JPS63119469A/ja active Granted
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO154346C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater. | |
NO156611C (no) | Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre. | |
NO153177C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater. | |
NO151966C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazol-5-eddiksyrederivater | |
NO145915C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive karboksyalkylacylaminosyrer | |
NO151321C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater | |
NO151463C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater | |
NO147450C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater | |
NO153136C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive naftyridinderivater. | |
NO148813C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive karbostyrilderivater | |
NO152935C (no) | Analogifremgangsmaate for fremstilling av anti-inflammatorisk virksomme tioetiansyrederivater. | |
NO159019C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive 6beta-hydroksyalkylpenicillansyrederivater. | |
NO154522C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinderivater. | |
NO153569C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater. | |
NO145379C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamider. | |
NO148777C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater | |
NO146095C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater | |
NO152654C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive derivater av 7-acylamido-3-cephem-4-karboksylsyre | |
NO802087L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyrederivater | |
NO151500C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazoloksamsyre-derivater | |
NO781878L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner. | |
NO151285C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater | |
NO148454C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater | |
NO151660C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater. | |
NO780644L (no) | Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater |